Literature DB >> 17114736

An outbreak of Rocky Mountain Spotted Fever associated with a novel tick vector, Rhipicephalus sanguineus, in Arizona, 2004: preliminary report.

Linda J Demma1, M Eremeeva, W L Nicholson, M Traeger, D Blau, C Paddock, M Levin, G Dasch, J Cheek, D Swerdlow, J McQuiston.   

Abstract

This study describes preliminary results of an investigation of RMSF in Arizona associated with the brown dog tick, Rhipicephalus sanguineus. High numbers of dogs and heavy infestations of ticks created a situation leading to human disease.

Entities:  

Mesh：

Year:  2006        PMID： 17114736     DOI： 10.1196/annals.1374.066

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  11 in total

1.  Rocky mountain spotted fever characterization and comparison to similar illnesses in a highly endemic area-Arizona, 2002-2011.

Authors:  Marc S Traeger; Joanna J Regan; Dwight Humpherys; Dianna L Mahoney; Michelle Martinez; Ginny L Emerson; Danielle M Tack; Aimee Geissler; Seema Yasmin; Regina Lawson; Charlene Hamilton; Velda Williams; Craig Levy; Kenneth Komatsu; Jennifer H McQuiston; David A Yost
Journal:  Clin Infect Dis       Date:  2015-02-19       Impact factor: 9.079

2.  Ticks and tick-borne pathogens of dogs along an elevational and land-use gradient in Chiriquí province, Panamá.

Authors:  A Michelle Ferrell; R Jory Brinkerhoff; Juan Bernal; Sergio E Bermúdez
Journal:  Exp Appl Acarol       Date:  2017-04-17       Impact factor: 2.132

3.  Biology and ecology of the brown dog tick, Rhipicephalus sanguineus.

Authors:  Filipe Dantas-Torres
Journal:  Parasit Vectors       Date:  2010-04-08       Impact factor: 3.876

4.  Phylogeography of Rhipicephalus sanguineus sensu lato and its relationships with climatic factors.

Authors:  Galina E Zemtsova; Dmitry A Apanaskevich; Will K Reeves; Micah Hahn; Alyssa Snellgrove; Michael L Levin
Journal:  Exp Appl Acarol       Date:  2016-03-22       Impact factor: 2.132

Review 5.  Transmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne Diseases.

Authors:  Girish Neelakanta; Hameeda Sultana
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-12-12       Impact factor: 4.291

6.  Infection of domestic dogs in peru by zoonotic bartonella species: a cross-sectional prevalence study of 219 asymptomatic dogs.

Authors:  Pedro Paulo V P Diniz; Bridget A Morton; Maryam Tngrian; Malika Kachani; Eduardo A Barrón; Cesar M Gavidia; Robert H Gilman; Noelia P Angulo; Elliott C Brenner; Richard Lerner; Bruno B Chomel
Journal:  PLoS Negl Trop Dis       Date:  2013-09-05

7.  Prevalence of Vector-Borne Pathogens in Southern California Dogs With Clinical and Laboratory Abnormalities Consistent With Immune-Mediated Disease.

Authors:  L Kidd; B Qurollo; M Lappin; K Richter; J R Hart; S Hill; C Osmond; E B Breitschwerdt
Journal:  J Vet Intern Med       Date:  2017-05-30       Impact factor: 3.333

8.  A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Ehrlichia species in domestic dogs within the contiguous United States.

Authors:  Yan Liu; Robert B Lund; Shila K Nordone; Michael J Yabsley; Christopher S McMahan
Journal:  Parasit Vectors       Date:  2017-03-09       Impact factor: 3.876

9.  Evidence for increasing densities and geographic ranges of tick species of public health significance other than Ixodes scapularis in Québec, Canada.

Authors:  Salima Gasmi; Catherine Bouchard; Nicholas H Ogden; Ariane Adam-Poupart; Yann Pelcat; Erin E Rees; François Milord; Patrick A Leighton; Robbin L Lindsay; Jules K Koffi; Karine Thivierge
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

10.  Predicting the northward expansion of tropical lineage Rhipicephalus sanguineus sensu lato ticks in the United States and its implications for medical and veterinary health.

Authors:  Emily L Pascoe; Santiago Nava; Marcelo B Labruna; Christopher D Paddock; Michael L Levin; Matteo Marcantonio; Janet E Foley
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.